Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• A Systematic Review of Multidimensional Predictors for Refractory Chronic Rhinosinusitis: Clinical, Systemic and Local Insights1 passage
• A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy1 passage
• Adverse Outcomes Associated With Short-Acting Beta-Agonist Overuse in Asthma: A Systematic Review and Meta-Analysis1 passage
• Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis1 passage
• Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis1 passage
• Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments1 passage
• Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments1 passage
• Antibiotics for Acute Wheezing and Asthma Exacerbations: An EAACI Position Paper and Systematic Review1 passage
• Artemisia annua-sublingual immunotherapy for seasonal allergic rhinitis: A randomized controlled trial1 passage
• Baseline type 2 biomarker levels and response to tezepelumab in severe asthma1 passage
• Biologicals in atopic disease in pregnancy: An EAACI position paper1 passage
• Clinical Benefits of a Randomized Allergy App Intervention in Grass Pollen Sufferers: A Controlled Trial1 passage
• Comorbidity of chronic spontaneous urticaria and autoimmune thyroid diseases: A systematic review1 passage
• Comparative Efficacy of Seven Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Network Meta-Analysis1 passage
• Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement1 passage
• Cost-Effectiveness of Allergen Immunotherapy for Allergic Rhinitis: A Systematic Review1 passage
• Diagnosing, managing and preventing anaphylaxis: Systematic review1 passage
• Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper1 passage
• Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut Allergy1 passage
• Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS-52 is unaffected by eosinophilic status1 passage
• EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis1 passage
• EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma1 passage
• EAACI Guidelines on Environmental Science for Allergy and Asthma-Recommendations on the Impact of Indoor Air Pollutants on the Risk of New-Onset Asthma and on Asthma-Related Outcomes1 passage
• EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy1 passage
• EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy1 passage
• EAACI guidelines on the management of IgE-mediated food allergy1 passage
• EAACI guidelines: Anaphylaxis (2021 update)1 passage
• EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity1 passage
• Early initiation of short-term emollient use for the prevention of atopic dermatitis in high-risk infants-The STOP-AD randomised controlled trial1 passage
• Economic evidence for nonpharmacological asthma management interventions: A systematic review1 passage
• Effect of Intramuscular Adrenaline on Histamine-Induced Hypotension: A Randomised Placebo-Controlled Pilot Trial1 passage
• Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta-Analysis of Real-World Evidence1 passage
• Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines1 passage
• Efficacy and safety of intranasal medications for allergic rhinitis: Network meta-analysis1 passage
• Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma1 passage
• Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma1 passage
• Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma1 passage
• Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals Guidelines1 passage
• Efficacy of Aspirin Therapy After Desensitization on Chronic Rhinosinusitis With Nasal Polyps Patients With Asthma and Non-steroidal Anti-inflammatory Drug Exacerbated Respiratory Disease -A Randomized Clinical Trial1 passage
• Emollients for prevention of atopic dermatitis: 5-year findings from the BEEP randomized trial1 passage
• Frequency of food allergy in Europe: An updated systematic review and meta-analysis1 passage
• Genotype-Guided Asthma Treatment Reduces Exacerbations in Children: Meta-Analysis of Two Randomized Control Trials1 passage
• Head-To-Head Comparison of Biologic Efficacy in Asthma: What Have We Learned?1 passage
• Impact of Residential Greeness Exposure on the Development of Allergic Diseases and Asthma and on Asthma Control-A Systematic Review for the EAACI Guidelines of Environmental Science for Allergic Diseases and Asthma1 passage
• Is exposure to pollen a risk factor for moderate and severe asthma exacerbations?1 passage
• Meta-Analysis on the Harm of Systemic Glucocorticosteroids in Inflammatory Upper Airway Disease and Asthma: An EAACI Task Force1 passage
• Nasal allergen-neutralizing antibodies correlate closely with tolerated intranasal allergen challenge dose following grass pollen subcutaneous immunotherapy in patients with local allergic rhinitis1 passage
• Patients' values and preferences for health states in allergic rhinitis-An artificial intelligence supported systematic review1 passage
• Patterns and Clinical Efficacy of Biologics Switching in Patients With Severe Asthma: A Systematic Review and Meta-Analysis23 passages
• Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients1 passage
• Predictors of Response to Biologics for Severe Asthma: A Systematic Review and Meta-Analysis25 passages
• Prenatal antibiotic exposure, asthma, and the atopic march: A systematic review and meta-analysis1 passage
• Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food-A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper1 passage
• Risk factors for severe reactions in food allergy: Rapid evidence review with meta-analysis1 passage
• SQ House Dust Mite Sublingual Immunotherapy Tablet in Children With Allergic Asthma: A Randomised Phase III Trial1 passage
• Six Injections of Modified Adjuvanted PQ Grass Is Effective and Well-Tolerated in a Pivotal Phase III Trial1 passage
• State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)1 passage
• Symptomatic treatment of pollen-related allergic rhinoconjunctivitis in children: randomized controlled trial1 passage
• Systematic Review and Meta-Analysis of Oral Immunotherapy Effect on Food Allergy-Related Quality of Life1 passage
• Systemic treatments in the management of atopic dermatitis: A systematic review and meta-analysis1 passage
• The impact of exposure to tobacco smoke and e-cigarettes on asthma-related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma1 passage
• The impact of outdoor pollution and extreme temperatures on asthma-related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma1 passage
• The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria1 passage
• The maternal diet index in pregnancy is associated with offspring allergic diseases: the Healthy Start study1 passage
• Understanding the Variability of Peanut-Oral Immunotherapy Responses by Multi-Omics Profiling of Immune Cells1 passage
• Understanding the challenges faced by adolescents and young adults with allergic conditions: A systematic review1 passage
• Vitamin D supplementation during pregnancy and infancy reduces aeroallergen sensitization: a randomized controlled trial1 passage
• Vitamin D supplementation in primary allergy prevention: Systematic review of randomized and non-randomized studies1 passage